Randomized controlled trial: Moxibustion and acupuncture for the treatment of Crohn’s disease

Table 2 Patient characteristics at baseline

Characteristics	Treatment group	Control group	P value1
Age (yr); mean ± SD	36.98 ± 14.46	32.38 ± 11.83	0.113
Gender (male/female)	27/16	25/17	0.757
Height (cm)	167.47 ± 9.20	166.71 ± 6.79	0.670
Weight (kg)	53.69 ± 11.73	53.44 ± 11.73	0.924
Duration of disease (yr)	4.64 ± 3.75	4.67 ± 4.51	0.978
Prior resection (yes/no)	8/35	4/38	0.229
Severity (mild/moderate)	24/19	30/12	0.135
CDAI	210.84 ± 48.03	201.04 ± 57.13	0.394
IBDQ	157.67 ± 30.43	157.36 ± 33.19	0.963
HGB	118.05 ± 17.79	124.79 ± 20.70	0.111
ESR	21.80 ± 16.86	24.64 ± 22.28	0.625
CRP	18.52 ± 24.35	12.32 ± 13.43	0.164
Concomitant medication	27	24	0.398
Aminosalicylates	16	11
Corticosteroids	2	3
Aminosalicylates and corticosteroids	9	10
Montreal classification
Age at diagnosis
A1	2	3	0.373
A2	32	33
A3	9	6
Location
L1	6	8	0.251
L2	8	11
L3	29	23
L4	0	0
Behavior
B1	12	9	0.853
B2	2	2
B3	10	12
B1P	7	10
B2P	3	1
B3P	9	8

¹P values from comparisons between the treatment and control groups. CDAI: Crohn’s disease activity index; IBDQ: Inflammatory bowel disease questionnaire; HGB: Hemoglobin; ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein.